References
- Cuckle H, Platt LD, Thornburg LL, et al. Nuchal translucency quality review (NTQR) program: first one and half million results. Ultrasound Obstet Gynecol 2014. [Epub ahead of print]. doi: 10.1002/uog.13390
- Nicolaides KH, Bindra R, Heath V, Cicero S. One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation. J Matern Fetal Neonatal Med 2002;12:9–18
- Haak MC, van Vugt JM. Pathophysiology of increased nuchal translucency: a review of the literature. Hum Reprod Update 2003;9:175–84 (review)
- De Domenico R, Faraci M, Hyseni E, et al. Increased nuchal translucency in normal karyotype fetuses. J Prenat Med 2011;5:23–6
- Bilardo CM, Timmerman E, Pajkrt E, van Maarle M. Increased nuchal translucency in euploid fetuses – what should we be telling the parents? Prenat Diagn 2010;30:93–102
- Nicolaides KH, Heath V, Liao AW. The 11–14 week scan. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:581–94 (review)
- Roccella EJ. Considerations for evaluating community high blood pressure control programmes. J Hum Hypertens 1996;10(Suppl 1):S17–19
- Carpenter MW, Coustan DR. Criteria for screening test for gestational diabetes. Am J Obstet Gynecol 1982;157:758–63
- Owen P, Donnet ML, Ogston SA, et al. Standards for ultrasound fetal growth velocity. Br J Obstet Gynaecol 1996;103:60–9
- Zwahlen M, Gerber S, Bersinger NA. First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels. Gynecol Obstet Invest 2007;63:15–21
- Hourrier S, Salomon LJ, Dreux S, Muller F. Screening for adverse pregnancy outcome at early gestational age. Clin Chim Acta 2010;11:1547–52
- Tsai MS, Lee FK, Cheng CC, et al. Association between fetal nuchal translucency thickness in first trimester and subsequent gestational hypertension and preeclampsia. Prenat Diagn 2002;22:747–51
- Luchi C, Schifano M, Nanini C, et al. Does nuchal translucency thickness in the first trimester predict GDM onset during pregnancy? Gynecol Endocrinol 2011;27:782–4
- Sheizaf B, Sheiner E, Fink M, et al. A significant linear association exists between nuchal translucency thickness and adverse perinatal outcome in euploid fetuses. J Matern Fetal Neonatal Med 2009;22:479–84
- Kelekci S, Yilmaz B, Savan K, Sonmez S. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus? J Obstet Gynaecol 2005;25:579–82
- Papastefanou I, Souka AP, Pilalis A, et al. First trimester prediction of small- and large-for-gestation neonates by an integrated model incorporating ultrasound parameters, biochemical indices and maternal characteristics. Acta Obstet Gynecol Scand 2012;91:104–11
- Tul N, Pusenjak S, Osredkar J, et al. Predicting complications of pregnancy with first-trimester maternal serum free beta hCG, PAPP-A and inhibin A. Prenat Diagn 2003;23:990–6
- Krantz D, Goetzl L, Simpson JL, et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004;191:1452–8
- Clemente CM, Farina M, Cianci A, Iraci Sareri M. Sirenomelia with oligodactylia: early ultrasonographic and hysteroscopic embryoscopic diagnosis during the first trimester of gestation. Fetal Diagn Ther 2010;28:43–5
- Schwendemann WD, Contag SA, Koty PP, et al. Ultrasound findings in trisomy 22. Am J Perinatol 2009;26:135–7